Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis.
Breast cancer
Neoadjuvant treatment
Personalized medicine
Radiomics
Journal
Current problems in cancer
ISSN: 1535-6345
Titre abrégé: Curr Probl Cancer
Pays: United States
ID NLM: 7702986
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
15
04
2022
revised:
22
06
2022
accepted:
27
06
2022
pubmed:
2
8
2022
medline:
4
10
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
We performed a systematic review and a meta-analysis of studies using MRI-radiomics for predicting the pathological complete response in breast cancer patients undergoing neoadjuvant therapy , and we evaluated their methodological quality using the radiomics-quality-score (RQS). Random effects meta-analysis was performed pooling area under the receiver operating characteristics curves. Publication-bias was assessed using the Egger's test and visually inspecting the funnel plot. Forty-three studies were included in the qualitative review and 34 in the meta-analysis. Summary area under the receiver operating characteristics curve was 0,78 (95%CI:0,74-0,81). Heterogeneity according to the I
Identifiants
pubmed: 35914383
pii: S0147-0272(22)00043-5
doi: 10.1016/j.currproblcancer.2022.100883
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100883Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Conflict of Interest All the authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.